Veradermics, Incorporated (MANE) — Working Capital to Net Assets Ratio
Veradermics, Incorporated (MANE) has a Working Capital to Net Assets ratio of 99.6% as of March 2026. Working capital of $390.35 Million (current assets of $397.07 Million minus current liabilities of $6.72 Million) is measured against net assets of $391.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Read MANE current and long-term liabilities for a breakdown of total debt and financial obligations.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Veradermics, Incorporated Working Capital to Net Assets (2023–2025)
This chart shows how Veradermics, Incorporated's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 99.6%, reflecting working capital of $390.35 Million against net assets of $391.87 Million USD. Explore Veradermics, Incorporated (MANE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Working Capital to Net Assets for Veradermics, Incorporated (2023–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Veradermics, Incorporated from 2023 to 2025, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Veradermics, Incorporated.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -118.5% | $143.34 Million | $-121.01 Million | $152.49 Million | $9.15 Million | ▼ -211.4 pp |
| 2024 | 93.0% | $50.82 Million | $54.66 Million | $55.53 Million | $4.72 Million | ▼ -6.3 pp |
| 2023 | 99.3% | $14.51 Million | $14.62 Million | $17.56 Million | $3.05 Million | — |